These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16187434)

  • 1. Insulin resistance, kidney damage, and gender.
    Kordella T
    Diabetes Forecast; 2005 Sep; 58(9):40. PubMed ID: 16187434
    [No Abstract]   [Full Text] [Related]  

  • 2. Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences.
    Gall MA
    Dan Med Bull; 1997 Nov; 44(5):465-85. PubMed ID: 9408734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Specifics of diabetic nephropathy, viewpoint in diabetology: trends of diabetic nephropathy in diabetes].
    Krempf M
    Nephrol Ther; 2006 May; 2 Suppl 3():S190-2. PubMed ID: 17370849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for chronic kidney disease in patients with diabetes mellitus].
    Kes P; Basić-Jukić N; Furić-Cunko V
    Lijec Vjesn; 2010; 132(9-10):316-7. PubMed ID: 21261032
    [No Abstract]   [Full Text] [Related]  

  • 5. [Routine screening for microalbuminemia in type 2 diabetes mellitus--con].
    Sawicki PT
    Dtsch Med Wochenschr; 2003 May; 128(21):1188. PubMed ID: 12761693
    [No Abstract]   [Full Text] [Related]  

  • 6. [Routine screening for microalbuminemia in type 2 diabetes mellitus--pro].
    Dikow R; Ritz E
    Dtsch Med Wochenschr; 2003 May; 128(21):1187. PubMed ID: 12761692
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H; Sone H; Oishi M; Kawai K; Fukumoto Y; Kobayashi M;
    Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes.
    Estacio RO; Coll JR; Tran ZV; Schrier RW
    Am J Hypertens; 2006 Dec; 19(12):1241-8. PubMed ID: 17161769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The kidneys and diabetes].
    Rüster C; Sämann A; Wolf G
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 12. Kidney disease in diabetology: lessons from 2008.
    Schernthaner G
    Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of microalbuminuria by using losartan in normotensive patients with type 2 diabetes mellitus: A randomized controlled trial.
    Agha A; Amer W; Anwar E; Bashir K
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):429-35. PubMed ID: 19414946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Futrakul P
    Am J Kidney Dis; 2009 Sep; 54(3):583-4. PubMed ID: 19700066
    [No Abstract]   [Full Text] [Related]  

  • 16. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
    Murussi M; Campagnolo N; Beck MO; Gross JL; Silveiro SP
    Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance is an independent correlate of increased urine albumin excretion: a cross-sectional study in Iranian Type 2 diabetic patients.
    Esteghamati A; Ashraf H; Nakhjavani M; Najafian B; Hamidi S; Abbasi M
    Diabet Med; 2009 Feb; 26(2):177-81. PubMed ID: 19236623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
    Zoppini G; Targher G; Chonchol M; Perrone F; Lippi G; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):580-6. PubMed ID: 19196499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.